Table 5.
V-ATPase |
Cyclophosphamide |
Gemcitabine |
Doxorubicin |
Paclitaxel |
Cisplatin |
||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
R | LS | MS | HS | p value | R | LS | MS | HS | p value | R | LS | MS | HS | p value | R | LS | MS | HS | p value | R | LS | MS | HS | p value | |
_ |
0 |
9 |
4 |
1 |
χ2 = 20.68 |
0 |
2 |
8 |
4 |
χ2 = 21.45 |
0 |
1 |
6 |
7 |
χ2 = 17.47 |
1 |
0 |
2 |
11 |
χ2 = 15.12 |
2 |
2 |
6 |
4 |
χ2 = 21.04 |
+ |
10 |
19 |
2 |
0 |
p = 0.002 |
3 |
6 |
20 |
2 |
p = 0.002 |
13 |
6 |
7 |
5 |
p = 0.008 |
1 |
0 |
5 |
25 |
p = 0.004 |
5 |
10 |
11 |
7 |
p = 0.002 |
++ | 4 | 0 | 0 | 0 | rs = −0.584 | 2 | 2 | 0 | 0 | rs = −0.512 | 2 | 2 | 0 | 0 | rs = −0.544 | 2 | 0 | 2 | 0 | rs = −0.269 | 4 | 0 | 0 | 0 | rs = −0.306 |
R: Resistance; LS: Low sensitivity; MS: Moderate sensitivity; HS: High sensitivity.